Ludvikova V - Search Results

1

DNA vaccine against oncogenic hamster cells transformed by HPV16 E6/E7 oncogenes and the activated ras oncogene.

Smahel M, Sobotkova E, Vonka V, Hamsikova E, Zak R, Kitasato H, Ludvikova V. Smahel M, et al. Among authors: ludvikova v. Oncol Rep. 1999 Jan-Feb;6(1):211-5. doi: 10.3892/or.6.1.211. Oncol Rep. 1999. PMID: 9864430

2

Immunisation with modified HPV16 E7 genes against mouse oncogenic TC-1 cell sublines with downregulated expression of MHC class I molecules.

Smahel M, Síma P, Ludvíková V, Marinov I, Pokorná D, Vonka V. Smahel M, et al. Among authors: ludvikova v. Vaccine. 2003 Mar 7;21(11-12):1125-36. doi: 10.1016/s0264-410x(02)00519-4. Vaccine. 2003. PMID: 12559790

3

DNA vaccines based on chimeric potyvirus-like particles carrying HPV16 E7 peptide (aa 44-60).

Pokorna D, Cerovska N, Smahel M, Moravec T, Ludvikova V, Mackova J, Synkova H, Duskova M, Hozak P, Veleminsky J. Pokorna D, et al. Among authors: ludvikova v. Oncol Rep. 2005 Oct;14(4):1045-53. Oncol Rep. 2005. PMID: 16142370

4

Enhancement of T cell-mediated and humoral immunity of beta-glucuronidase-based DNA vaccines against HPV16 E7 oncoprotein.

Smahel M, Poláková I, Pokorná D, Ludvíková V, Dusková M, Vlasák J. Smahel M, et al. Among authors: ludvikova v. Int J Oncol. 2008 Jul;33(1):93-101. Int J Oncol. 2008. PMID: 18575754

5

Prospective study on cervical neoplasia IV. Presence of HPV antibodies.

Vonka V, Hamsíková E, Kanka J, Ludvíková V, Sapp M, Smahel M. Vonka V, et al. Among authors: ludvikova v. Int J Cancer. 1999 Jan 29;80(3):365-8. doi: 10.1002/(sici)1097-0215(19990129)80:3<365::aid-ijc5>3.0.co;2-c. Int J Cancer. 1999. PMID: 9935175

6

Metastatic MHC class I-negative mouse cells derived by transformation with human papillomavirus type 16.

Smahel M, Sobotková E, Bubeník J, Símová J, Zák R, Ludviková V, Hájková R, Kovarík J, Jelínek F, Povýsil C, Marinov J, Vonka V. Smahel M, et al. Among authors: ludvikova v. Br J Cancer. 2001 Feb 2;84(3):374-80. doi: 10.1054/bjoc.2000.1615. Br J Cancer. 2001. PMID: 11225590 Free PMC article.

7

Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells.

Smahel M, Síma P, Ludvíková V, Vonka V. Smahel M, et al. Among authors: ludvikova v. Virology. 2001 Mar 15;281(2):231-8. doi: 10.1006/viro.2000.0794. Virology. 2001. PMID: 11277695 Free article.

8

Use of polyclonal rabbit antibodies for detection of the bcr-abl fusion zone in cells transfected with experimental bcr-abl DNA vaccines.

Ludvíková V, Hamsíková E, Sobotková E, Lucansky V, Smahel M, Vonka V. Ludvíková V, et al. Int J Oncol. 2005 Jul;27(1):265-74. doi: 10.3892/ijo.27.1.265. Int J Oncol. 2005. PMID: 15942668

9

In vitro and in vivo effects of reovirus on HPV16-transformed mice cells.

Figova K, Sobotkova E, Duskova M, Ludvikova V, Vonka V, Eckschlager T. Figova K, et al. Among authors: ludvikova v. Neoplasma. 2010;57(3):207-14. doi: 10.4149/neo_2010_03_207. Neoplasma. 2010. PMID: 20353270

10

Combined immunization with fusion genes of mutated E7 gene of human papillomavirus type 16 did not enhance antitumor effect.

Pokorná D, Macková J, Dusková M, Rittich S, Ludvíková V, Smahel M. Pokorná D, et al. Among authors: ludvikova v. J Gene Med. 2005 Jun;7(6):696-707. doi: 10.1002/jgm.733. J Gene Med. 2005. PMID: 15712328

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters